Regulatory Information
HSA regulatory responsibility and product classification details
Regulatory Responsibility
RegistrantFRESENIUS KABI (SINGAPORE) PTE LTD
Product Classification
D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification
Formulation Information
INJECTION, SOLUTION
INTRAVENOUS, SUBCUTANEOUS
Medical Information
L01BC01
Manufacturer Information
FRESENIUS KABI (SINGAPORE) PTE LTD
Fresenius Kabi Oncology Ltd.
Active Ingredients
Documents
Package Inserts
Cytarine Kabi Solution for Injection or Infusion PI.pdf
Approved: December 18, 2024